{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T07:40:45Z","timestamp":1783064445648,"version":"3.54.6"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005385","name":"Council for Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Colloid and Interface Science"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jcis.2020.12.021","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T22:40:39Z","timestamp":1609454439000},"page":"156-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Multidomain drug delivery systems of \u03b2-casein micelles for the local oral co-administration of antiretroviral combinations"],"prefix":"10.1016","volume":"592","author":[{"given":"Prakram","family":"Singh Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Abutbul Ionita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hen","family":"Moshe Halamish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Sosnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dganit","family":"Danino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcis.2020.12.021_b0005","unstructured":"The global HIV\/AIDS epidemic. Available from: https:\/\/www.hiv.gov\/hiv-basics\/overview\/data-and-trends\/global-statistics, 2019 (accessed on 3 May 2020)."},{"issue":"6","key":"10.1016\/j.jcis.2020.12.021_b0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/14656566.2018.1450866","article-title":"Next generation fixed dose combination pharmacotherapies for treating HIV","volume":"19","author":"Caplan","year":"2018","journal-title":"Expert Opinion Pharmacother."},{"issue":"1","key":"10.1016\/j.jcis.2020.12.021_b0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09354-z","article-title":"Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies","volume":"10","author":"Hobson","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jcis.2020.12.021_b0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax."},{"key":"10.1016\/j.jcis.2020.12.021_b0025","article-title":"Can an anti-HIV combination or other existing drugs outwit the new coronavirus?","author":"Cohen","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jcis.2020.12.021_b0030","unstructured":"H. C. Coronavirus puts drug repurposing on the fast track. 2020 Journal [2020 17 March].Available from: https:\/\/www.nature.com\/articles\/d41587-020-00003-1, 2020 (accessed on 17 March 2020)."},{"key":"10.1016\/j.jcis.2020.12.021_b0035","unstructured":"\u201cSolidarity\u201d clinical trial for COVID-19 treatments. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/global-research-on-novel-coronavirus-2019-ncov\/solidarity-clinical-trial-for-covid-19-treatments."},{"issue":"3","key":"10.1016\/j.jcis.2020.12.021_b0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2215\/CJN.02240218","article-title":"Clinical Pharmacology in HIV Therapy","volume":"14","author":"Atta","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.jcis.2020.12.021_b0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.apsb.2018.01.012","article-title":"Anti-retroviral drugs: current state and development in the next decade","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta. Pharm. Sin. B."},{"key":"10.1016\/j.jcis.2020.12.021_b0050","doi-asserted-by":"crossref","unstructured":"N. Paengsai, G. Jourdain, N. Salvadori, A. Tantraworasin, J.Y. Mary, T.R. Cressey, R. Chaiwarith, C. Bowonwatanuwong, S. Bhakeecheep, N. Kosachunhanun, Recommended first-line antiretroviral therapy regimens and risk of diabetes mellitus in HIV-infected adults in resource-limited settings, in Open Forum Infect. Dis. 2019. Oxford University Press US.","DOI":"10.1093\/ofid\/ofz298"},{"key":"10.1016\/j.jcis.2020.12.021_b0055","unstructured":"WHO model lists of essential medicines. https:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/, 2019 (accessed on 12 May 2020)."},{"key":"10.1016\/j.jcis.2020.12.021_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144917","article-title":"Tipranavir\/ritonavir (500\/200 mg and 500\/100 mg) was virologically non-inferior to lopinavir\/ritonavir (400\/100 mg) at week 48 in treatment-na\u00efve HIV-1-infected patients: a randomized, multinational, multicenter trial","volume":"11","author":"Cooper","year":"2016","journal-title":"Plos One."},{"key":"10.1016\/j.jcis.2020.12.021_b0065","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1177\/1060028017717018","article-title":"Cobicistat versus ritonavir: similar pharmacokinetic enhancers but some important differences","volume":"51","author":"Tseng","year":"2017","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jcis.2020.12.021_b0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40265-013-0160-x","article-title":"Cobicistat: a review of its use as a pharmacokinetic enhancer of atazanavir and darunavir in patients with HIV-1 infection","volume":"74","author":"Deeks","year":"2014","journal-title":"Drugs."},{"issue":"7","key":"10.1016\/j.jcis.2020.12.021_b0075","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/jac\/dkw032","article-title":"Cobicistat versus ritonavir boosting and differences in the drug\u2013drug interaction profiles with co-medications","volume":"71","author":"Marzolini","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jcis.2020.12.021_b0080","first-page":"175","article-title":"Profile of once-daily darunavir\/cobicistat fixed-dose combination for the treatment of HIV\/AIDS","volume":"8","author":"Navarro","year":"2016","journal-title":"HIV\/AIDS (Auckl)."},{"key":"10.1016\/j.jcis.2020.12.021_b0085","first-page":"1","article-title":"Clinical use of cobicistat as a pharmacoenhancer of human immunodeficiency virus therapy","volume":"8","author":"von Hentig","year":"2016","journal-title":"HIV\/AIDS (Auckl)."},{"key":"10.1016\/j.jcis.2020.12.021_b0090","first-page":"5763","article-title":"Rationale and clinical utility of the darunavir\u2013cobicistat combination in the treatment of HIV\/AIDS","volume":"9","author":"Putcharoen","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"issue":"2","key":"10.1016\/j.jcis.2020.12.021_b0095","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jps.23380","article-title":"Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Efavirenz","volume":"102","author":"Cristofoletti","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jcis.2020.12.021_b0100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejpb.2016.09.014","article-title":"Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers","volume":"109","author":"Rubbens","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jcis.2020.12.021_b0105","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jps.10566","article-title":"Ritonavir\u2013PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations","volume":"93","author":"Law","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jcis.2020.12.021_b0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.biomaterials.2014.10.026","article-title":"Novel protease inhibitor-loaded Nanoparticle-in-Microparticle Delivery System leads to a dramatic improvement of the oral pharmacokinetics in dogs","volume":"37","author":"Imperiale","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jcis.2020.12.021_b0115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.actbio.2018.04.045","article-title":"Nanoparticle-in-microparticle oral drug delivery system of a clinically relevant darunavir\/ritonavir antiretroviral combination","volume":"74","author":"Augustine","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jcis.2020.12.021_b0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2009.05.007","article-title":"Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing ahead","volume":"138","author":"Sosnik","year":"2009","journal-title":"J. Control. Release."},{"key":"10.1016\/j.jcis.2020.12.021_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2016.06.010","article-title":"Biomedical engineering approaches for HIV\/AIDS Prophylaxis, diagnostics and therapy","volume":"103","author":"Neves","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jcis.2020.12.021_b0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.addr.2015.12.022","article-title":"Challenges in oral drug delivery of antiretrovirals and the innovative strategies to overcome them","volume":"103","author":"Sosnik","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"15","key":"10.1016\/j.jcis.2020.12.021_b0135","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1021\/jf060119c","article-title":"Micellization of Bovine \u03b2-Casein Studied by Isothermal Titration Microcalorimetry and Cryogenic Transmission Electron Microscopy","volume":"54","author":"Portnaya","year":"2006","journal-title":"J. Agric. Food Chem."},{"issue":"7","key":"10.1016\/j.jcis.2020.12.021_b0140","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1021\/la702802a","article-title":"Effect of Temperature on Self-Assembly of Bovine \u03b2-Casein above and below Isoelectric pH. Structural Analysis by Cryogenic-Transmission Electron Microscopy and Small-Angle X-ray Scattering","volume":"24","author":"Moitzi","year":"2008","journal-title":"Langmuir"},{"issue":"2","key":"10.1016\/j.jcis.2020.12.021_b0145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2012.01.004","article-title":"Development and characterization of a novel drug nanocarrier for oral delivery, based on self-assembled \u03b2-casein micelles","volume":"160","author":"Bachar","year":"2012","journal-title":"J. Control. Release."},{"key":"10.1016\/j.jcis.2020.12.021_b0150","doi-asserted-by":"crossref","first-page":"7183","DOI":"10.1021\/acs.langmuir.5b01397","article-title":"Celecoxib encapsulation in \u03b2-casein micelles: structure, interactions, and conformation","volume":"31","author":"Turovsky","year":"2015","journal-title":"Langmuir."},{"key":"10.1016\/j.jcis.2020.12.021_b0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1515\/ejnm-2015-0023","article-title":"Thermotropic behavior of celecoxib-loaded beta-casein micelles: relevance to the improved bioavailability","volume":"7","author":"Perlstein","year":"2015","journal-title":"Eur. J. Nanomed."},{"key":"10.1016\/j.jcis.2020.12.021_b0160","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2016.07.051","article-title":"Role of nanoparticle size, shape and surface chemistry in oral drug delivery","volume":"238","author":"Banerjee","year":"2016","journal-title":"J. Control. Release."},{"key":"10.1016\/j.jcis.2020.12.021_b0165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/pharmaceutics11030129","article-title":"Challenges and recent progress in oral drug delivery systems for biopharmaceuticals","volume":"11","author":"Homayun","year":"2019","journal-title":"Pharmaceutics."},{"issue":"2","key":"10.1016\/j.jcis.2020.12.021_b0170","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s11483-016-9429-4","article-title":"Denaturation and in Vitro Gastric Digestion of Heat-Treated Quinoa Protein Isolates Obtained at Various Extraction pH","volume":"11","author":"Ruiz","year":"2016","journal-title":"Food Biophys."},{"issue":"6","key":"10.1016\/j.jcis.2020.12.021_b0175","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cocis.2012.10.003","article-title":"Cryo-TEM of soft molecular assemblies","volume":"17","author":"Danino","year":"2012","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.jcis.2020.12.021_b0180","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cis.2015.05.003","article-title":"Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers","volume":"223","author":"Sosnik","year":"2015","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.jcis.2020.12.021_b0185","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","article-title":"Freeze-drying of nanoparticles: formulation, process and storage considerations","volume":"58","author":"Abdelwahed","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jcis.2020.12.021_b0190","doi-asserted-by":"crossref","first-page":"26821","DOI":"10.1039\/C7CP05303G","article-title":"PEG coated vesicles from mixtures of Pluronic P123 and l-\u03b1-phosphatidylcholine: structure, rheology and curcumin encapsulation","volume":"19","author":"Dutta","year":"2017","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"1","key":"10.1016\/j.jcis.2020.12.021_b0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02294-6","article-title":"Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy","volume":"9","author":"Kirtane","year":"2018","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.jcis.2020.12.021_b0200","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11481-010-9198-7","article-title":"Nanoformulated Antiretroviral Drug Combinations Extend Drug Release and Antiretroviral Responses in HIV-1-Infected Macrophages: Implications for NeuroAIDS Therapeutics","volume":"5","author":"Nowacek","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"7","key":"10.1016\/j.jcis.2020.12.021_b0205","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1128\/AAC.01564-09","article-title":"Pharmacokinetics of Darunavir at 900 Milligrams and Ritonavir at 100 Milligrams Once Daily when Coadministered with Efavirenz at 600 Milligrams Once Daily in Healthy Volunteers","volume":"54","author":"Soon","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcis.2020.12.021_b0210","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ijbiomac.2018.02.016","article-title":"Eudragit\u00ae L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery","volume":"113","author":"Xu","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.jcis.2020.12.021_b0215","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/02652048.2018.1515997","article-title":"Novel revaprazan-loaded gelatin microsphere with enhanced drug solubility and oral bioavailability","volume":"35","author":"Kim","year":"2018","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jcis.2020.12.021_b0220","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0268-005X(01)00080-7","article-title":"Secondary structural studies of bovine caseins: temperature dependence of \u03b2-casein structure as analyzed by circular dichroism and FTIR spectroscopy and correlation with micellization","volume":"15","author":"Farrell","year":"2001","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.jcis.2020.12.021_b0225","doi-asserted-by":"crossref","first-page":"501","DOI":"10.15255\/CABEQ.2015.2311","article-title":"Characterization of casein fractions\u2013Comparison of commercial casein and casein extracted from cow\u2019s milk","volume":"30","author":"Pti\u010dek Siro\u010di\u0107","year":"2016","journal-title":"Chem. Biochem. Eng."},{"key":"10.1016\/j.jcis.2020.12.021_b0230","first-page":"2097","article-title":"Development of enteric submicron particle formulation of papain for oral delivery","volume":"6","author":"Sharma","year":"2011","journal-title":"Int. J. Nanomedicine."},{"issue":"1","key":"10.1016\/j.jcis.2020.12.021_b0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1517\/17425247.2013.736962","article-title":"Eudragit\u00ae: a technology evaluation","volume":"10","author":"Thakral","year":"2013","journal-title":"Expert Opin. Drug. Deliv."},{"key":"10.1016\/j.jcis.2020.12.021_b0240","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1039\/C8NH00415C","volume":"4","author":"Ding","year":"2019","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.jcis.2020.12.021_b0245","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1039\/C9NH00344D","volume":"4","author":"Ding","year":"2019","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.jcis.2020.12.021_b0250","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1039\/C8NH00307F","volume":"4","author":"Yang","year":"2019","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.jcis.2020.12.021_b0255","volume":"14","author":"Hu","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.jcis.2020.12.021_b0260","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jclepro.2014.05.046","article-title":"Approach to ecofriendly leather: characterization and application of an alkaline protease for chemical free dehairing of skins and hides at pilot scale","volume":"79","author":"George","year":"2014","journal-title":"J. Cleaner Prod."}],"container-title":["Journal of Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979720316775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979720316775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:28:03Z","timestamp":1762194483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021979720316775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":52,"alternative-id":["S0021979720316775"],"URL":"https:\/\/doi.org\/10.1016\/j.jcis.2020.12.021","relation":{},"ISSN":["0021-9797"],"issn-type":[{"value":"0021-9797","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidomain drug delivery systems of \u03b2-casein micelles for the local oral co-administration of antiretroviral combinations","name":"articletitle","label":"Article Title"},{"value":"Journal of Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcis.2020.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}